400 related articles for article (PubMed ID: 26648664)
1. Sphingolipids in High Fat Diet and Obesity-Related Diseases.
Choi S; Snider AJ
Mediators Inflamm; 2015; 2015():520618. PubMed ID: 26648664
[TBL] [Abstract][Full Text] [Related]
2. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.
Garbowska M; Łukaszuk B; Mikłosz A; Wróblewski I; Kurek K; Ostrowska L; Chabowski A; Żendzian-Piotrowska M; Zalewska A
J Cell Physiol; 2017 Oct; 232(10):2766-2775. PubMed ID: 28369933
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
Roszczyc-Owsiejczuk K; Zabielski P
Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
[TBL] [Abstract][Full Text] [Related]
5. TNFα gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice.
Salles J; Tardif N; Landrier JF; Mothe-Satney I; Guillet C; Boue-Vaysse C; Combaret L; Giraudet C; Patrac V; Bertrand-Michel J; Denis P; Chardigny JM; Boirie Y; Walrand S
J Nutr Biochem; 2012 Dec; 23(12):1685-93. PubMed ID: 22464148
[TBL] [Abstract][Full Text] [Related]
6. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet.
Boini KM; Zhang C; Xia M; Poklis JL; Li PL
J Pharmacol Exp Ther; 2010 Sep; 334(3):839-46. PubMed ID: 20543095
[TBL] [Abstract][Full Text] [Related]
7. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
8. Ceramides and Sphingosino-1-Phosphate in Obesity.
Juchnicka I; Kuźmicki M; Szamatowicz J
Front Endocrinol (Lausanne); 2021; 12():635995. PubMed ID: 34054722
[TBL] [Abstract][Full Text] [Related]
9. Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts.
Mastrocola R; Dal Bello F; Cento AS; Gaens K; Collotta D; Aragno M; Medana C; Collino M; Wouters K; Schalkwijk CG
Free Radic Biol Med; 2021 Jun; 169():425-435. PubMed ID: 33905864
[TBL] [Abstract][Full Text] [Related]
10. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.
Bruce CR; Risis S; Babb JR; Yang C; Lee-Young RS; Henstridge DC; Febbraio MA
Endocrinology; 2013 Jan; 154(1):65-76. PubMed ID: 23183172
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
12. Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.
Gosejacob D; Jäger PS; Vom Dorp K; Frejno M; Carstensen AC; Köhnke M; Degen J; Dörmann P; Hoch M
J Biol Chem; 2016 Mar; 291(13):6989-7003. PubMed ID: 26853464
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity.
Charytoniuk T; Sztolsztener K; Bielawiec P; Chabowski A; Konstantynowicz-Nowicka K; Harasim-Symbor E
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216351
[TBL] [Abstract][Full Text] [Related]
14. CerS1-Derived C
Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
[TBL] [Abstract][Full Text] [Related]
15. Black elderberry extract attenuates inflammation and metabolic dysfunction in diet-induced obese mice.
Farrell NJ; Norris GH; Ryan J; Porter CM; Jiang C; Blesso CN
Br J Nutr; 2015 Oct; 114(8):1123-31. PubMed ID: 26314315
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
Holland WL; Summers SA
Endocr Rev; 2008 Jun; 29(4):381-402. PubMed ID: 18451260
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet.
Wu Y; Wu T; Wu J; Zhao L; Li Q; Varghese Z; Moorhead JF; Powis SH; Chen Y; Ruan XZ
J Endocrinol; 2013 Dec; 219(3):195-204. PubMed ID: 24029730
[TBL] [Abstract][Full Text] [Related]
18. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
[TBL] [Abstract][Full Text] [Related]
19. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid Profiling Reveals Different Extent of Ceramide Accumulation in Bovine Retroperitoneal and Subcutaneous Adipose Tissues.
Leung YH; Christiane Bäßler S; Koch C; Scheu T; Meyer U; Dänicke S; Huber K; Kenéz Á
Metabolites; 2020 Nov; 10(11):. PubMed ID: 33228142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
